Braine-le-château, Belgium

Marc Georges Francis Massaer

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Biologicals S.a.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Georges Francis Massaer. Retrieved from https://idiyas.com/inventor/marc-georges-francis-massaer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Marc Georges Francis Massaer

Introduction

Marc Georges Francis Massaer is an accomplished inventor based in Braine le Chateau, Belgium. He has made significant contributions to the field of allergy treatment through his innovative research and development. His work focuses on creating solutions that minimize allergic responses, showcasing his commitment to improving public health.

Latest Patents

Massaer holds a patent for a recombinant allergen with reduced enzymatic activity. This novel treatment aims to provide a safer alternative for individuals suffering from allergies. By reducing the potential for an allergic response upon contact with a wild-type allergen, his invention represents a significant advancement in allergy management.

Career Highlights

Massaer is currently employed at SmithKline Beecham Biologicals S.A., where he continues to work on groundbreaking research in the field of immunology. His expertise and dedication have positioned him as a valuable asset to the company and the scientific community.

Collaborations

Throughout his career, Massaer has collaborated with notable colleagues, including Claudine Bruck and Alex Bollen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Marc Georges Francis Massaer is a prominent figure in the field of allergy treatment, with a focus on developing safer therapeutic options. His contributions through his patent and work at SmithKline Beecham Biologicals S.A. highlight his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…